Skip to main content

Table 8 Trial management

From: Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: A multi-centre, double-masked, factorial randomised controlled trial

Core trial management committee

Richard Lee

Chief Investigator (Ophthalmology), University of Bristol and Bristol Eye Hospital, UK

Colin Dayan

Chief Investigator (Endocrinology), University of Bristol and Bristol Royal Infirmary, UK

Jimmy Uddin

Principal investigator (Ophthalmology), Moorfields Eye Hospital. London, UK

Rathie Rajendram

Co-investigator (Ophthalmology), Moorfields Eye Hospital, London, UK

Catey Bunce

Medical statistician, Moorfields Eye Hospital, London, UK

Trial Steering Committee

Maarten P Mourits

Professor of Ophthalmology, Academic Medical Centre, Amsterdam, NL

John Lazarus

Professor of Endocrinology, University of Wales, Cardiff, UK

John Sparrow

Consultant Ophthalmologist, Bristol Eye Hospital, UK

Data Monitoring Committee

John Forrester

Professor of Ophthalmology, University of Aberdeen and Aberdeen Royal Infirmary, UK

Gillian Adams

Consultant Ophthalmologist, Moorfields Eye Hospital, London, UK

Roberto Melotti

Senior statistician, North Bristol NHS Trust, Bristol, UK